and my key take out, last sentence in first paragraph and last paragraph, they are hopeful of approval soon in SR-aGVHD. I'm sure the window is still open to Trade this stock but be wary as an announcement might be around the corner.
"Total cash payments for operating activities was US$22.0 million, a reduction of 2.8% relative to the comparative quarter of 2019. Spending on clinical programs reduced by US$4.2 million during the period compared to the comparative quarter of 2019. This was partially offset by investment in manufacturing and commercial activities for the expected US launch of RYONCIL (remestemcel-L) in SR-aGVHD.
"Mesoblast is in active discussions with US and other government authorities as well as potential pharmaceutical partners with respect to its plans for ramp-up of commercial manufacturing for remestemcel-L in COVID-19 ARDS.2"
and my key take out, last sentence in first paragraph and last...
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |